Financial results - OPIUM PHARMA MED SRL

Financial Summary - Opium Pharma Med Srl
Unique identification code: 30410355
Registration number: J40/7930/2012
Nace: 4773
Sales - Ron
-
Net Profit - Ron
-87
Employee
The most important financial indicators for the company Opium Pharma Med Srl - Unique Identification Number 30410355: sales in 2016 was - euro, registering a net profit of -87 euro and having an average number of employees. Firma isi desfasoara activitatea in domeniul Comert cu amanuntul al produselor farmaceutice, in magazine specializate having the NACE code 4773.

Sales, Profit, Employees, Debts, Capitals, Financial Results - Opium Pharma Med Srl

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR 233.989 58.773 0 - - - - - - -
Total Income - EUR 233.999 62.500 0 - - - - - - -
Total Expenses - EUR 290.056 57.602 96 - - - - - - -
Gross Profit/Loss - EUR -56.057 4.898 -96 - - - - - - -
Net Profit/Loss - EUR -56.057 4.898 -96 - - - - - - -
Employees 3 1 0 - - - - - - -
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded.

Check the financial reports for the company - Opium Pharma Med Srl

Rating financiar

Financial Rating -
Opium Pharma Med Srl

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Limite de plata

Payment Limits -
Opium Pharma Med Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Opium Pharma Med Srl

It determines the risk of insolvency based on the submitted accounting balance.

Check Insolvency Probability
Rapoarte financiare

Financial Reports -
Opium Pharma Med Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Opium Pharma Med Srl - CUI 30410355

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets 3.806 3.643 3.510 - - - - - - -
Current Assets 173.053 187.992 186.074 - - - - - - -
Inventories 37.424 26.681 26.409 - - - - - - -
Receivables 98.904 161.065 159.422 - - - - - - -
Cash 36.724 245 243 - - - - - - -
Shareholders Funds -85.096 -80.908 -80.179 - - - - - - -
Social Capital 56 56 56 - - - - - - -
Debts 229.512 239.829 269.763 - - - - - - -
Income in Advance 32.442 32.713 32.379 - - - - - - -
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "4773 - 4773"
CAEN Financial Year 4773
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 186.074 euro in 2016 which includes Inventories of 26.409 euro, Receivables of 159.422 euro and cash availability of 243 euro.
The company's Equity was valued at -80.179 euro, while total Liabilities amounted to 269.763 euro. Equity decreased by -96 euro, from -80.908 euro in 2015, to -80.179 in 2016. The Debt Ratio was 121.5% in the year 2016.

Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!

Reviews - Opium Pharma Med Srl

Comments - Opium Pharma Med Srl

Similar services useful for checking companies and business development.

Contacts Firms

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Company Lists

Create lists of companies for your sales activity according to your own criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.